| scholarly article | Q13442814 |
| P2093 | author name string | Robert B McCall | |
| Sean P Mahabir | |||
| Andrea J Gonzales | |||
| Timothy J Fleck | |||
| William R Humphrey | |||
| Betsy A Galvan | |||
| Jezaniah-Kira Tena | |||
| Karen G Greenwood | |||
| Michelle M Aleo | |||
| P2860 | cites work | Evidence-based veterinary dermatology: a systematic review of the pharmacotherapy of canine atopic dermatitis | Q28196384 |
| Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice | Q28265772 | ||
| IL-31: a new link between T cells and pruritus in atopic skin inflammation | Q28295839 | ||
| IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis | Q28295850 | ||
| Signaling by IL-31 and functional consequences | Q34222387 | ||
| The ACVD task force on canine atopic dermatitis (XIV): clinical manifestations of canine atopic dermatitis. | Q34366336 | ||
| Oclacitinib (APOQUEL(®)) is a novel Janus kinase inhibitor with activity against cytokines involved in allergy. | Q34402215 | ||
| Interleukin-31: a novel diagnostic marker of allergic diseases. | Q34403290 | ||
| A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client-owned dogs with atopic dermatitis | Q34866838 | ||
| IL-31 Serum Protein and Tissue mRNA Levels in Patients with Atopic Dermatitis | Q35590354 | ||
| Treatment of canine atopic dermatitis: 2015 updated guidelines from the International Committee on Allergic Diseases of Animals (ICADA). | Q35746839 | ||
| A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: Involvement of TRPV1 and TRPA1. | Q37649820 | ||
| Interventions for atopic dermatitis in dogs: a systematic review of randomized controlled trials | Q37699441 | ||
| The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights | Q37732574 | ||
| A systematic review of randomized controlled trials for prevention or treatment of atopic dermatitis in dogs: 2008-2011 update | Q38075150 | ||
| Canine atopic dermatitis - what have we learned? | Q38084237 | ||
| Review: Clinical and histological manifestations of canine atopic dermatitis | Q38353279 | ||
| Interleukin-31: its role in canine pruritus and naturally occurring canine atopic dermatitis | Q39208372 | ||
| Allergen-induced production of IL-31 by canine Th2 cells and identification of immune, skin, and neuronal target cells | Q44277975 | ||
| Distribution of IL-31 and its receptor expressing cells in skin of atopic dermatitis | Q44637159 | ||
| Epicutaneous sensitization with Dermatophagoides farinae induces generalized allergic dermatitis and elevated mite-specific immunoglobulin E levels in a canine model of atopic dermatitis | Q44873137 | ||
| Evaluation of a spontaneous canine model of immunoglobulin E-mediated food hypersensitivity: dynamic changes in serum and fecal allergen-specific immunoglobulin E values relative to dietary change. | Q44878327 | ||
| PCR detects bands consistent with the expression of receptors associated with pruritus in canine dorsal root ganglia | Q45167896 | ||
| The immunopathogenesis of flea allergy dermatitis in dogs, an experimental study | Q47624187 | ||
| The pharmacokinetics of oclacitinib maleate, a Janus kinase inhibitor, in the dog. | Q54453353 | ||
| Increased frequencies of IL-31-producing T cells are found in chronic atopic dermatitis skin | Q60168134 | ||
| Correlation of IL-31 serum levels with severity of atopic dermatitis | Q62073543 | ||
| Pruritic dermatitis in asthmatic basenji-greyhound dogs: A model for human atopic dermatitis | Q72689944 | ||
| IL-31 expression by inflammatory cells is preferentially elevated in atopic dermatitis | Q82280428 | ||
| Serum measurement of interleukin-31 (IL-31) in paediatric atopic dermatitis: elevated levels correlate with severity scoring | Q83370473 | ||
| Repeated administration of IL-31 upregulates IL-31 receptor A (IL-31RA) in dorsal root ganglia and causes severe itch-associated scratching behaviour in mice | Q85932633 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 34-e10 | |
| P577 | publication date | 2015-12-15 | |
| P1433 | published in | Veterinary Dermatology | Q15752609 |
| P1476 | title | IL-31-induced pruritus in dogs: a novel experimental model to evaluate anti-pruritic effects of canine therapeutics | |
| P478 | volume | 27 |
| Q64061987 | A blinded, randomized, placebo-controlled trial of the safety of oclacitinib in cats |
| Q95855813 | Antipruritic Effect of Ethyl Acetate Extract from Fructus cnidii in Mice with 2,4-Dinitrofluorobenzene-Induced Atopic Dermatitis |
| Q45601105 | Atopic Dermatitis in Animals and People: An Update and Comparative Review |
| Q39410617 | Emerging role of interleukin-31 and interleukin-31 receptor in pruritus in atopic dermatitis |
| Q48234007 | Investigation of the correlation of serum IL-31 with severity of dermatitis in an experimental model of canine atopic dermatitis using beagle dogs |
| Q89557788 | Multidose intramuscular allogeneic adipose stem cells decrease the severity of canine atopic dermatitis: A pilot study |
Search more.